CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling
| Image |  |
|---|---|
| Description | scientific article published on 21 November 2011 |
| Author/s |
author: Joerg F. Schlaak Michael A. Polis Richard A. Lempicki Guido Gerken |
| Publication date | November 21, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |